AbstractNeutralizing antibodies can protect against challenge with HIV-1 in vivo if present at appropriate concentrations at the time of viral challenge, but any role in the control of established infection is unclear. Here, we show that high serum concentrations of neutralizing monoclonal antibodies, either singly or as a cocktail, have little sustained effect on viral load in established HIV-1 infection in hu-PBL-SCID mice. In some instances, virus replication of neutralization-sensitive virus continues even in the presence of high levels of neutralizing antibody. In most instances, neutralization escape occurs in a few days, even from a cocktail of three antibodies that recognize distinct epitopes. The results imply that humoral immunity...
Neutralizing antibodies are a major component of host defense against viruses, and appear to be part...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...
Although a limited number of HIV-infected patients have broadly neutralizing antibodies, it has not ...
The titer of neutralizing antibodies elicited in plasma or sera correlate closely with protection fr...
AbstractAlthough the majority of primary HIV-1 variants can be neutralized by broadly neutralizing a...
Some HIV-1-infected patients develop broad and potent HIV-1 neutralizing antibodies (bNAbs) that whe...
The ability to induce neutralizing antibodies is generally thought to be of great importance for vac...
Antibody-mediated immunotherapy is effective in humanized mice when combinations of broadly neutrali...
textabstractRecently, conflicting data have been published about the ability of antibodies which eff...
Approximately 1 % of those infected with HIV-1 develop broad and potent serum cross-neutralizing ant...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
SummaryLatent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) an...
AbstractOccurrences of HIV-1 superinfection offer a unique opportunity to investigate the correlates...
Neutralizing antibodies are a major component of host defense against viruses, and appear to be part...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...
Although a limited number of HIV-infected patients have broadly neutralizing antibodies, it has not ...
The titer of neutralizing antibodies elicited in plasma or sera correlate closely with protection fr...
AbstractAlthough the majority of primary HIV-1 variants can be neutralized by broadly neutralizing a...
Some HIV-1-infected patients develop broad and potent HIV-1 neutralizing antibodies (bNAbs) that whe...
The ability to induce neutralizing antibodies is generally thought to be of great importance for vac...
Antibody-mediated immunotherapy is effective in humanized mice when combinations of broadly neutrali...
textabstractRecently, conflicting data have been published about the ability of antibodies which eff...
Approximately 1 % of those infected with HIV-1 develop broad and potent serum cross-neutralizing ant...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
SummaryLatent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) an...
AbstractOccurrences of HIV-1 superinfection offer a unique opportunity to investigate the correlates...
Neutralizing antibodies are a major component of host defense against viruses, and appear to be part...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...